Introduction
Endothelium-derived nitric oxide (NO) plays a vital role in the regulation of vasomotor tone and arterial blood pressure (for review see Moncada et al., 1991) . Evidence is accumulating to suggest that impaired NO-mediated vasodilatation contributes to increased peripheral vascular resistance associated with chronic heart failure (CHF). In clinical and experimental CHF it has been established that endothelium-dependent relaxation in response to acetylcholine is impaired (Drexler et al., 1992; Ramsey & Jones, 1994; Bauersachs et al., 1999) . In contrast, data on basal release of NO in CHF is controversial. Some studies suggest that basal release of NO is preserved or may even be enhanced in CHF (Drexler et al., 1992; Habib et al., 1994; Winlaw et al., 1994) , while other studies show that it is impaired (Elsner et al., 1991; Teerlink et al., 1994) . The aetiology of endothelial dysfunction associated with CHF is unclear and is likely to be complex.
The inducible isoform of nitric oxide synthase (iNOS) is expressed in the vasculature in response to in¯ammatory cytokines and pathogens (Moncada et al., 1991) . In¯amma-tory cytokines such as tumour necrosis factor-a are elevated in the plasma of patients with CHF (Katz et al., 1994) . Furthermore, iNOS has been reported by some investigators to be present in the myocardium (Fukuchi et al., 1998; Vejlstrup et al., 1998) and skeletal muscle (Adams et al., 1997) of patients with CHF. The role of iNOS in the vasculature has not been directly addressed in CHF. It has been suggested, however, that iNOS may be responsible for increased basal production of NO in CHF (Carville et al., 1998) .
Irrespective of its source, increased basal production of NO should counteract compensatory constrictor mechanisms and thus reduce peripheral vascular resistance. Increased superoxide production is associated with CHF (Belch et al., 1991) . Superoxide scavenges NO (Gryglewski et al., 1986) , therefore, a reduction in NO bioavailability may well explain why peripheral vascular resistance remains elevated in CHF despite a preserved or enhanced basal release of NO.
The aims of the present study were to determine if iNOS is expressed in isolated small mesenteric arteries from a rat model of CHF, to determine the functional signi®cance of this potential source of NO on vascular responsiveness and to investigate the role that superoxide plays in modulating vascular function in these arteries.
Methods

Coronary artery ligation model of CHF
All experiments were carried out in accordance with the Animals (Scienti®c Procedures) Act 1986. Myocardial infarction was induced in 5 week old male Wistar rats (250 ± 300 g, Charles River) by coronary artery ligation (CAL), as previously described (Pfeer et al., 1979) . In brief, rats were anaesthetized (sodium pentobarbitol; 60 mg kg 71 , i.p.), the thoracic cavity was opened and the heart exteriorized. Using a silk ligature, the left anterior descending coronary artery was tied. In control sham-operated rats, the ligature was not tied but pulled through under the coronary artery. After closure of the chest, animals were allowed to recover and were maintained on standard chow and water ad libitum.
Six weeks after surgery, rats were anaesthetized (sodium pentobarbitol; 60 mg kg 71 , i.p.), the right carotid artery was isolated and a Millar pressure transducer-tipped catheter (2F, model SPR 407, Millar Instruments, Inc., Houston, TX, U.S.A.) introduced into the artery for measurement of arterial blood pressure. The catheter was then advanced into the left ventricle (LV) for measurement of left ventricular end-diastolic pressure (LVEDP) as an index of left ventricular function.
Following exsanguination, the mesenteric bed was excised, the gut removed and the remaining vascular bed placed into cold, oxygenated (95% O 2 , 5% CO 2 ), Krebs-Henseleit solution (composition, in mM: NaCl 118, KCl 4.7, CaCl 2 2.5, MgSO 4 1.2, KH 2 PO 4 1.2, NaHCO 3 25 and glucose 5.5) for functional studies. Sections of the mesenteric bed from both CAL and sham-operated rats were placed in 10% neutral phosphate buered formalin for ®xation. The hearts and lungs were removed and weighed. Hearts were bisected, ®xed in formalin as above for detection of mature collagen in the infarcted zone and measurement of infarct size.
Immunohistochemistry
Formalin ®xed mesenteric arteries from both CAL and shamoperated rats were processed in ethanol and embedded in paran wax. Three-mm sections were taken from blocks, dewaxed in xylene (10 min), rehydrated through a descending alcohol series (100, 90 and 70% alcohol; 3 min each) and washed in water (15 min). To expose antigenic sites, arteries were treated with 0.1% trypsin (diluted in Tris-buered saline; pH 7.8; 15 min). Arteries were then treated with antiiNOS monoclonal antibody for 24 h (48C), washed in phosphate buered saline (PBS; pH 7.6; 10 min) and treated with alkaline phosphatase-conjugated goat anti-rabbit IgG for 30 min (room temperature). To detect iNOS within arteries, sections were treated with an alkaline phosphatase substrate and red fuchsin as a chromogen (*20 min). Negative controls were treated with an antibody of the same immunoglobulin class but not directed against the iNOS epitope. Tissues were counterstained with Harris' haematoxylin (BDH, Poole, U.K.).
Measurement of infarct size
Hearts were processed as above and 3 mm sections taken from paran blocks. After dewaxing and rehydration, hearts were treated with Van Gieson's stain for detection of collagen formation in infarctions. Infarct size was measured in sections as previously described (Mulder et al., 1998) . Sections were placed under a CCD video camera module (Sony, U.K.) attached to a microscope with a 620 lens. The endocardial and epicardial circumferences of the infarcted tissue and of the LV were determined with image analysis software (Imaging Associates, U.K.). Infarct size was calculated as a percentage [endocardial+epicardial circumference of the infarcted LV (mm)/endocardial+epicardial circumference (mm)] of the whole LV.
Preparation of arteries from mesenteric bed
Third order branches of the mesenteric artery (*3 mm length, internal diameter; 300 ± 350 mm) were dissected free of the bed and mounted between two microcannulae in a small vessel pressure myograph (Living Systems Instrumentation Inc., Burlington, U.S.A.). Arteries were constantly superfused with warm (378C), oxygenated (95% O 2 , 5% CO 2 ) Krebs-Henseleit solution. The intraluminal pressure of the vessel was raised to 60 mmHg and maintained at this level with a pressure servo unit without further intraluminal perfusion. A pressure of 60 mmHg was chosen because it has been estimated that vessels of this size would experience pressures approximately 50% of mean arterial pressure in vivo (Halpern & Kelley, 1991) . Luminal diameter was measured using a video dimension analyser (Living Systems Instrumentation Inc., Burlington, U.S.A.) and a calibrated hand micrometer, when the optical dimension analyser was unable to detect dierences in optical density at smaller lumen diameters.
After an equilibration period of 60 min, arteries were exposed twice in succession, separated by washout, to modi®ed Krebs-Henseleit solution containing 60 mM KCl (equimolar replacement of NaCl by KCl) to obtain maximal constriction. Arteries were then exposed twice to a supramaximal concentration of phenylephrine (PE; 10 75 M). In all arteries the endothelial integrity was tested by measuring ACh-induced relaxation (10 75 M) of PE-induced tone (10 75 M), with maximal relaxation indicating the presence of an intact endothelium. In some arteries, the endothelium was removed by passing an air bubble through the vessel lumen by a method previously described (Falloon et al., 1993) , and successful denudation veri®ed by loss of ACh-induced relaxation (10 75 M). After sucient washout and re-equilibration, arteries were constantly superfused in a closed system with a total volume of 30 ml warm (378C), oxygenated (95% O 2 , 5% CO 2 ) Krebs-Henseleit solution. All drugs used throughout this study were applied to this 30 ml reservoir, removing 1 ml of Krebs-Henseleit solution and replacing with the drug being added (as previously described, Mickley et al., 1997) .
Responses were recorded 5 min after addition of drug in order to allow time for responses to reach equilibrium. Four arteries were isolated from each CAL and sham-operated rat and the following experiments carried out in a random order.
Experimental protocols
Vascular responsiveness of arteries from coronary artery ligation and sham-operated rats To assess vascular responsiveness of small mesenteric arteries from CAL and sham-operated rats to adrenoceptor stimulation, cumulative concentration response curves (CRC) to PE (1610 79 to 3610 75 M) were constructed in endothelium-intact (n=8) and endothelium-denuded (n=6) arteries. Following completion of CRCs all vessels were repeatedly washed and allowed to re-equilibrate before further experiments.
Eect of iNOS inhibition on vascular responsiveness
To investigate the role of iNOS in modulating vascular responsiveness, endothelium-intact mesenteric arteries were exposed to the iNOS inhibitor, N-(3-(Aminomethyl) benzyl) acetamidine dihydrochloride (1400W; 10 76 M, n=8) for 30 min prior to repeating cumulative CRCs to PE (1610 79 to 3610
At this concentration, 1400W has been shown to inhibit the activity of iNOS in isolated rat aortic rings treated with lipopolysaccharide, without modifying the release of NO from endothelial NOS (eNOS) (Garvey et al., 1997) . 1400W was present in the superfusate throughout the CRC.
Eect of superoxide quenching on vascular responsiveness To investigate the role that superoxide plays in modulating vascular responsiveness, endothelium-intact mesenteric arteries were exposed to the superoxide dismutase ( MnTMPyP has been shown to protect endothelial-derived NO from destruction by superoxide in an in vitro model of oxidative stress (MacKenzie & Martin, 1998) . MnTMPyP was present in the superfusate throughout the CRC.
Eect of combined iNOS inhibition and superoxide quenching on vascular responsiveness
To further investigate the role of iNOS and superoxide in modulating vascular responsiveness, endothelium-intact mesenteric arteries were exposed to the iNOS inhibitor, 1400W (10 76 M, n=8) and the SOD mimetic, MnTMPyP (10 74 M, n=8) for 30 min prior to repeating cumulative CRC's to PE (1610 79 to 3610 75 M). Both drugs were present in the superfusate throughout the CRC.
Eect of NOS substrate on vascular responsiveness To investigate the eect of the NOS substrate, L-arginine, on vascular responsiveness, endothelium-denuded mesenteric arteries were exposed to a supramaximal concentration (Schott et al., 1993) 
Analysis of data
All results were expressed as means+s.e.mean. Where maximal values were obtained for cumulative CRCs, the negative logarithm of the agonist concentration that results in a half-maximal constriction or relaxation (pD 2 ) was calculated. Two-tailed t-tests, one-way analysis of variance (ANOVA) with Bonferroni multiple comparisons post-test and two-way repeated measures ANOVA were used as indicated in the text. P50.05 was considered to be statistically signi®cant.
Results
Eect of left coronary artery ligation
All the animals that survived the ®rst 24 h after CAL surgery (76%) were still alive 6 weeks later. There were no signi®cant dierences between rat weights for CAL and sham-operated groups at 6 weeks after surgery (Table 1) . Heart weights (corrected for body weight) for CAL rats were signi®cantly greater than those of sham-operated rats despite the presence of large infarcts (P50.05, two-tailed unpaired t-test, Table 1 ), indicating that hearts from CAL rats had undergone compensatory hypertrophy as a result of left ventricular infarction. There were no signi®cant dierences between groups with respect to lung weights and arterial blood pressures (Table 1 ). LVEDPs measured from CAL rats were signi®cantly greater than those for sham-operated rats (P50.05, two-tailed unpaired t-test, Table 1 ). CAL rats had left ventricular infarctions averaging 60+3% of the LV free wall. Additionally there was histological evidence for mature collagen scar formation within the infarcted zone (not shown). 
Immunohistochemistry
Immunoreactive iNOS was found in endothelial cells, vascular smooth muscle (VSM) cells and in the adventitia of small mesenteric arteries from CAL rats (Figure 1) . No immunoreactivity was found in mesenteric arteries from sham-operated rats (Figure 1 ) or in negative controls using IgG antibodies (not shown).
KCl, PE maximal constrictions and endothelial integrity
There were no signi®cant dierences between endotheliumintact and endothelium-denuded small mesenteric arteries from CAL and sham-operated groups with respect to internal diameters at rest and in response to KCl (60 mM; Table 2 ). However, maximal constriction to PE was signi®cantly greater in endothelium-denuded than in endothelium-intact mesenteric arteries from both CAL and sham-operated rats (P50.05, one-way ANOVA with Bonferroni post-test, Table 2 ). All endothelium-intact small mesenteric arteries studied had functional endothelium (CAL, 101.3+4%; sham-operated, 95.9+3% relaxations to ACh) and no signi®cant dierences in maximal relaxations were found between CAL and shamoperated groups (Table 2) .
Assessment of vascular responsiveness to adrenoceptor stimulation in coronary artery ligation and sham-operated rats
In both endothelium-intact and endothelium-denuded small mesenteric arteries from CAL and sham-operated rats, cumulative additions of PE (1610 79 to 3610 75 M) resulted in concentration-dependent constrictions (Figure 2a,b) . In endothelium-intact arteries from CAL rats, cumulative CRCs to PE were shifted signi®cantly to the left when compared with responses in sham-operated groups, indicating that arteries from CAL rats were more responsive to PE than those from sham-operated rats (P50.05, two-way ANOVA, Figure 2a) . Indeed, pD 2 values for PE CRCs in arteries from CAL rats were signi®cantly greater than those in sham-operated rats (CAL, 6.2+0.1; sham-operated, 5.9+0.1, P50.05, two-tailed unpaired t-test). There was no signi®cant dierence between maximal constrictions observed in arteries from CAL and sham-operated rats (Figure 2a) .
In endothelium-denuded arteries no signi®cant dierences were found between CAL and sham-operated rats with respect to PE CRCs (Figure 2b ). In addition, there were no signi®cant dierences between pD 2 values (CAL, 6.3+0.3; shamoperated, 5.9+0.2) and maximal % constrictions (Figure 2b) .
Eect of 1400W and MnTMPyP on vascular responsiveness
Treatment of endothelium-intact arteries from CAL rats with 1400W (10 76 M) or MnTMPyP (10 74 M) shifted PE CRCs to the right with respect to responses in untreated arteries (P50.05 for both, two-way ANOVA, Figure 3a) , indicating a reduction in responsiveness to PE. pD 2 values were signi®cantly decreased in the presence of 1400W or MnTMPyP when compared with untreated arteries (untreated, 6.3+0.1; 1400W, 5.9+0.1; MnTMPyP, 5.8+0.1, P50.05, one-way ANOVA with Bonferroni post-test). Responses to PE in arteries from CAL rats treated with 1400W or MnTMPyP were not signi®cantly dierent from those in sham-operated arteries (Figure 3a) . Responses to PE in endothelium-intact arteries from sham-operated rats were unaected by 1400W (10 76 M) or MnTMPyP (10 74 M) (Figure 3b ). In a similar fashion to those arteries treated with 1400W (10 76 M) or MnTMPyP (10 74 M) alone, combined treatment with both drugs resulted in signi®cant reduction in responsiveness of arteries from CAL rats to PE (P50.01 two-way ANOVA, Figure 3a) . pD 2 values were signi®cantly decreased in the presence of 1400W and MnTMPyP when compared with untreated arteries (untreated, 6.3+0.1; 1400W+MnTMPyP, 5.7+0.2, P50.01, one-way ANOVA with Bonferroni posttest). However, no dierences were found when compared with responses in arteries treated with 1400W alone. In arteries from sham-operated rats, combined treatment had no signi®cant eect on responses to PE (Figure 3b ).
Eect of L-arginine on vascular responsiveness
Treatment of endothelium-denuded arteries from CAL rats with the NOS substrate, L-arginine (10 73 M) for 30 min shifted PE CRCs to the right with respect to untreated arteries (P50.05, two-way ANOVA, Figure 4a ), indicating that in the presence of L-arginine arteries are less responsive to PE. pD 2 values could not be calculated as maximal constrictions were not reached. L-arginine had no signi®cant eect on PE responses in arteries from sham-operated rats (Figure 4b ).
Endothelium-dependent relaxations: eect of superoxide quenching
Following induction of PE-induced tone (CAL, 49.1+2.3%; sham-operated, 52.6+2.4% of maximal PE constriction) in endothelium-intact arteries from CAL and sham-operated rats, cumulative additions of ACh (1610 710 to 3610
resulted in concentration-dependent relaxations. pD 2 values for cumulative CRCs in arteries from CAL rats were signi®cantly lower than those in sham-operated rats, indicating that endothelium-dependent relaxations were blunted in small mesenteric arteries from CAL rats (CAL, 7.4+0.1; shamoperated, 7.9+0.2, P50.05, two-tailed unpaired t-test). Maximum relaxations to ACh were achieved in most arteries at a concentration of 3610 76 M and no signi®cant dierences were found between CAL and sham-operated groups (CAL, 104.1+3.5%; sham-operated, 102.4+2.4%).
In the presence of MnTMPyP (10 74 M), relaxations to ACh in arteries from CAL rats were signi®cantly enhanced, with a signi®cant increase in pD 2 values (untreated 7.4+0.1; MnTMPyP, 7.9+0.2, P50.05, two-tailed paired t-test). Treatment of arteries from sham-operated rats with MnTMPyP had no signi®cant eect on ACh CRCs.
Discussion
The salient ®nding of this study is that iNOS is expressed in mesenteric arteries from rats with CHF. However, despite the presence of iNOS, endothelium-intact small mesenteric arteries from CHF rats were found to be more responsive to phenylephrine that those from sham-operated rats. Hyperesponsiveness of endothelium-intact arteries from CAL rats was reversed by the iNOS inhibitor, 1400W and by the SODmimetic, MnTMPyP. Furthermore, supplementation of endothelium-denuded arteries from CAL rats with the NOS substrate resulted in a signi®cant reduction in responsiveness to phenylephrine. These results suggest that substrate de®cient, iNOS-derived superoxide may be responsible for the vascular dysfunction associated with this model of CHF.
Increased cytokine levels may serve as a stimulus for iNOS expression in CHF (Katz et al., 1994) . Indeed, iNOS is expressed in the myocardium (Fukuchi et al., 1998; Vejlstrup et al., 1998) and skeletal muscle (Adams et al., 1997) in clinical CHF. In the present study, iNOS was expressed in endothelial cells, VSM cells and in the adventitia in small mesenteric arteries from rats with CHF, but not in arteries from shamoperated rats. This is the ®rst study to demonstrate iNOS expression in the peripheral vasculature in experimental CHF. These ®ndings are in contrast to a recent study, which failed to detect iNOS in thoracic aortae from rats 8 weeks after myocardial infarction (Bauersachs et al., 1999) . Dierences in vessel type may explain this discrepancy. Moreover, rats used in the present study had larger infarcts than those used in the aforementioned study, perhaps suggesting that the severity of the model in¯uences iNOS expression.
During endotoxemia, expression of iNOS in the vasculature, and the subsequent production of NO, plays an important role in the vascular hyporeactivity to vasoconstrictors (for review see Thiemermann, 1994) . Therefore, in this model of CHF, increased production of NO from iNOS would be expected to reduce vascular responsiveness to phenylephrine. Somewhat paradoxically, endothelium-intact small me- senteric arteries from CHF rats were more responsive to phenylephrine than arteries from sham-operated rats. There was no signi®cant dierence between responses to phenylephrine in endothelium-denuded arteries from CHF or shamoperated rats, demonstrating that this vascular dysfunction is dependent on the presence of the endothelium. Basal NO from eNOS serves to dampen the eects of vasoconstrictors. One could speculate, therefore, that decreased basal release of NO is responsible for the hyperesponsiveness to phenylephrine. Teerlink et al. (1994) showed increased adrenergic responsiveness of thoracic aortic rings from rats with CHF, which was dependent on the presence of the endothelium. Furthermore, their study demonstrated that impaired basal release of NO from the endothelium was responsible for this vascular dysfunction.
To investigate the role that iNOS plays in modulating vascular function in this model of CHF we used a novel selective iNOS inhibitor, 1400W, and the NOS substrate, Larginine. 1400W is an irreversible inhibitor of iNOS that is at least 1000 fold more selective for iNOS than eNOS in rats (Garvey et al., 1997) . Furthermore, 1400W is eective in abolishing iNOS activity and attenuating hypotension associated with endotoxemia in rats (Wray et al., 1998) . In the present study we show, somewhat surprisingly, that inhibition of iNOS with 1400W reversed, rather than potentiated, the hyperesponsiveness of small mesenteric arteries from CHF rats. These results suggest that induction of iNOS does not result in the expected increase in NO generation. Instead, expression of the enzyme appears to be a major contributory factor in the hyperesponsive nature of endothelium-intact CHF arteries. In experimental endotoxemia addition of the NOS substrate, L-arginine, to isolated blood vessels increases NO production from iNOS and potentiates hyporesponsiveness to vasoconstrictors (Julou-Schaeer et al., 1990 ). Here we show that supplementation of endothelium-denuded small mesenteric arteries from CHF rats, but not sham-operated rats, with a supramaximal concentration of L-arginine results in a reduction in responsiveness to phenylephrine, presumably through production of NO from iNOS. These results suggest that although iNOS is present in small mesenteric arteries from CHF rats, it is unable to synthesize NO because there is insucient substrate. Recent studies have shown that iNOS, when de®cient in its substrate/cofactors, produces superoxide rather than NO (Xia & Zweier, 1997; Xia et al., 1998) . Therefore, in this model of CHF, it is possible that a de®ciency in L-arginine will not only prevent iNOS from generating NO but will also result in the enzyme producing superoxide. Increased scavenging of NO by superoxide would result in a reduction in the bioavailability of endothelium-derived NO, which may explain the marked increase in responsiveness of endothelium-intact arteries from CHF rats to phenylephrine.
To determine if increased superoxide production plays a role in modulating vascular function in this model of CHF, we used the cell permeable metalloporphyrin SOD mimetic, MnTMPyP. In a similar fashion to 1400W, MnTMPyP reversed the hyperesponsiveness of endothelium-intact small mesenteric arteries from CHF rats. This implies that mesenteric arteries from CHF rats are indeed generating superoxide, which is responsible for the marked elevation in responsiveness to phenylephrine. Numerous studies have demonstrated increased superoxide production in CHF (McMurray et al., 1990; Belch et al., 1991; Bauersachs et al., 1999) . NADH/NADPH oxidases (Bauersachs et al., 1999) , autoxidation of catecholamines, increased arachidonate metabolism and in¯ammatory cytokines have all been suggested as possible sources of superoxide in CHF (for review see Givertz & Colucci, 1998) . In the present study, however, both inhibition of iNOS and superoxide quenching reverses the hyperesponsiveness to phenylephrine suggesting that iNOS is the source of superoxide in this model of CHF. Indeed, there were no signi®cant dierences between responses to phenylephrine in arteries treated with 1400W alone and those treated with both 1400W and MnTMPyP.
Although MnTMPyP has been shown to protect SOD-null E. coli against oxidant stress (Faulkner et al., 1994) , recent studies provide evidence that MnTMPyP may actually scavenge NO itself and directly inhibit the activity of eNOS (Pfeier et al., 1998; Mackenzie et al., 1999) . Mackenzie et al. demonstrated an augmentation of phenylephrine-induced constrictions by MnTMPyP in isolated rat aortic rings that is reversed by inhibition of eNOS. However, in the present study MnTMPyP reduced responsiveness to phenylephrine in endothelium-intact small mesenteric arteries from CHF rats and had no signi®cant eect on responses in arteries from sham-operated rats. We are convinced, therefore, that the eects of MnTMPyP in the present study are a direct consequence of its SOD-mimetic properties.
This study presents an interesting new facet to the impact of iNOS in CHF. In this model of CHF, instead of generating large quantities of NO, iNOS appears to be generating superoxide, perhaps because of a de®ciency in its substrate, L-arginine. Moreover, this increase in superoxide production is responsible for the hyperesponsive nature of endotheliumintact small mesenteric arteries from rats with CHF. The precise mechanism and time course by which superoxide results in arteries being hyperesponsive is unclear from these experiments alone. However, the fact that the hypereactivity is dependent on the endothelium suggests that increased scavenging of basal, eNOS-derived NO by superoxide is responsible. In addition to impaired basal release of NO, we also show that ACh-mediated endothelium-dependent relaxations are impaired in arteries from rats with CHF. Moreover, relaxations to ACh were improved in the presence of MnTMPyP.
In summary, the present study suggests that substrate de®cient, iNOS-derived superoxide is responsible for increased responsiveness of endothelium-intact mesenteric arteries, possibly as a result of impaired release of endothelial-derived NO. While it remains to be established if this study mirrors clinical CHF, our ®ndings may represent an important mechanism for the endothelial dysfunction and raised peripheral resistance associated with CHF.
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